Pouria Rafsanjani Nejad

Publication Activity (10 Years)

Years Active: 2021-2022
Publications (10 Years): 3

Top Topics

Tyrosine Kinase

Top Venues

Molecular cancer research : MCR

SLAS technology

Experimental biology and medicine (Maywood, N.J.)

This page only lists publications with an associated author ORCID identifier.

Publications

Sunil Singh, Astha Lamichhane, Pouria Rafsanjani Nejad, Jacob Heiss, Hannah Baumann, Ravindra Gudneppanavar, Nic D Leipzig, Michael C Konopka, Gary D Luker, Hossein Tavana
Therapeutic Targeting of Stromal-Tumor HGF-MET Signaling in an Organotypic Triple-Negative Breast Tumor Model. Molecular cancer research : MCR 20 (7) (2022)
Astha Lamichhane, Pradip Shahi Thakuri, Pouria Rafsanjani Nejad, Hossein Tavana
Modeling adaptive drug resistance of colorectal cancer and therapeutic interventions with tumor spheroids. Experimental biology and medicine (Maywood, N.J.) 246 (22) (2021)
Pouria Rafsanjani Nejad, Pradip Shahi Thakuri, Sunil Singh, Astha Lamichhane, Jacob Heiss, Hossein Tavana
Toxicity of Combinations of Kinase Pathway Inhibitors to Normal Human Cells in a Three-Dimensional Culture. SLAS technology 26 (3) (2021)